May 21, 2020
Correvio Obtains Final Order for Plan of Arrangement
May 15, 2020
Correvio Announces Results from Annual General and Special Meeting of Securityholders
May 06, 2020
Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA
May 04, 2020
Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19
May 01, 2020
Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA
Apr 08, 2020
Correvio Obtains Interim Order For Plan Of Arrangement
Mar 30, 2020
Correvio Reports Full Year 2019 Financial Results
Mar 16, 2020
ADVANZ PHARMA to Acquire Correvio
Mar 10, 2020
Correvio Partners with Hong Kong Teson Pharma Limited for the Commercialization of Aggrastat® in China
Mar 02, 2020
Correvio Responds to Market Activity
Jan 28, 2020
Correvio Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities
Dec 24, 2019
Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events
Dec 11, 2019
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
Dec 10, 2019
Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess(TM) For The Treatment Of Recent Onset Atrial Fibrillation
Dec 10, 2019
Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess(TM) For Recent Onset Atrial Fibrillation
Nov 25, 2019
Correvio to Present at the Piper Jaffray 31st Annual Healthcare Conference
Nov 18, 2019
Correvio Announces Presentation of New Brinavess(TM) Spectrum Data at the American Heart Association 2019 Annual Meeting
Nov 14, 2019
Correvio Reports Third Quarter 2019 Financial Results
Nov 07, 2019
Correvio to Report Third Quarter 2019 Financial Results
Nov 04, 2019
Correvio Announces FDA Advisory Committee Meeting to Review Brinavess(TM) for Recent Onset Atrial Fibrillation